A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension

Condition:   Prader-Willi Syndrome Interventions:   Drug: Pitolisant oral tablets;   Drug: Placebo oral tablet Sponsor:   Harmony Biosciences, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials